Author:
Neves David,Ramos Ruben,Raposo Luís,Baptista Sérgio,de Araújo Gonçalves Pedro
Reference85 articles.
1. Tobis J, Azarbal B, Slavin L. Assessment of intermediate severity coronary lesions in the catheterization laboratory. J Am Coll Cardiol. 2007;49(8):839–48.
2. Pijls NHJ, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van’t Veer M, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis. 5-year follow-up of the DEFER study. J Am Coll Cardiol. 2007;49(21):2105–11.
3. Pijls NHJ, Fearon WF, Tonino PAL, Siebert U, Ikeno F, Bornschein B, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-Year follow-up of the FAME (fractional flow reserve versus angiography for multivessel evaluation) study. J Am Coll Cardiol. Elsevier Inc. 2010;56(3):177–84.
4. De Bruyne B, Fearon WF, Pijls NHJ, Barbato E, Tonino P, Piroth Z, et al. Fractional flow reserve–guided PCI for stable coronary artery disease. N Engl J Med. 2014;371:1208–17.
5. Fearon WF, Shilane D, Pijls NHJ, Boothroyd DB, Tonino PAL, Barbato E. Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve. Circulation. 2013;128(12):1335–40.